MyAverix Finance
US · Healthcare
Santen Pharmaceutical Co (SNPHY)
Drug Manufacturers - General
Santen Pharmaceutical Co (SNPHY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SNPHY
Santen Pharmaceutical Co (SNPHY) — FAQ
What is SNPHY's P/E ratio?
The price-to-earnings (P/E) ratio for Santen Pharmaceutical Co (SNPHY) is 18.00 (data as of 2026-03-25).
Does Santen Pharmaceutical Co pay a dividend?
Dividend yield is not available in the current snapshot for Santen Pharmaceutical Co (SNPHY). Check the MyAverix Finance app for the latest dividend data.
What sector is Santen Pharmaceutical Co in?
Santen Pharmaceutical Co (SNPHY) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is SNPHY listed on?
SNPHY is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.